116 related articles for article (PubMed ID: 32810343)
1. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
Barré T; Nishimwe ML; Protopopescu C; Marcellin F; Carrat F; Dorival C; Delarocque-Astagneau E; Larrey D; Bourlière M; Petrov-Sanchez V; Simony M; Pol S; Fontaine H; Carrieri P;
J Viral Hepat; 2020 Dec; 27(12):1473-1483. PubMed ID: 32810343
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort.
Barré T; Carrat F; Ramier C; Fontaine H; Di Beo V; Bureau M; Dorival C; Larrey D; Delarocque-Astagneau E; Mathurin P; Marcellin F; Petrov-Sanchez V; Cagnot C; Carrieri P; Pol S; Protopopescu C;
J Cannabis Res; 2022 Jun; 4(1):31. PubMed ID: 35690798
[TBL] [Abstract][Full Text] [Related]
3. Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T; Bourlière M; Ramier C; Carrat F; Di Beo V; Protopopescu C; Marcellin F; Bureau M; Cagnot C; Dorival C; Zoulim F; Zucman-Rossi J; Duclos-Vallée JC; Fontaine H; Carrieri P; The Anrs/Afef Hepather Study Group
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294456
[TBL] [Abstract][Full Text] [Related]
4. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).
Nordmann S; Vilotitch A; Roux P; Esterle L; Spire B; Marcellin F; Salmon-Ceron D; Dabis F; Chas J; Rey D; Wittkop L; Sogni P; Carrieri P;
J Viral Hepat; 2018 Feb; 25(2):171-179. PubMed ID: 28984055
[TBL] [Abstract][Full Text] [Related]
5. Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Santos M; Protopopescu C; Delarocque-Astagneau E; Bourlière M; Petrov-Sanchez V; Di Beo V; Larrey D; Baudoin M; Dorival C; Bureau M; Fontaine H; Carrat F; Marcellin F; Pol S; Carrieri P;
Liver Int; 2022 Jan; 42(1):38-49. PubMed ID: 34520614
[TBL] [Abstract][Full Text] [Related]
6. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F;
Clin Infect Dis; 2015 Jul; 61(1):40-8. PubMed ID: 25778750
[TBL] [Abstract][Full Text] [Related]
7. Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort).
Barré T; Pol S; Ramier C; Di Beo V; Carrat F; Bureau M; Bourlière M; Dorival C; Serfaty L; Asselah T; Boursier J; Marcellin F; Carrieri P; Fontaine H; Protopopescu C;
Cannabis Cannabinoid Res; 2022 Oct; 7(5):677-689. PubMed ID: 34648718
[No Abstract] [Full Text] [Related]
8. Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort).
Barré T; Fontaine H; Ramier C; Di Beo V; Pol S; Carrieri P; Marcellin F; Cagnot C; Dorival C; Zucman-Rossi J; Zoulim F; Carrat F; Protopopescu C
Clin Nutr; 2022 Mar; 41(3):610-619. PubMed ID: 35124468
[TBL] [Abstract][Full Text] [Related]
9. Liver fibrosis and all-cause mortality in chronic HCV-infected diabetic patients: A paradoxical association? (ANRS CO22 HEPATHER).
Barré T; Ramier C; Di Beo V; Carrat F; Fontaine H; Marcellin F; Carrieri P; Pol S; Protopopescu C;
Liver Int; 2021 Jul; 41(7):1694-1698. PubMed ID: 33993651
[No Abstract] [Full Text] [Related]
10. Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Carrieri P; Bourlière M; Di Beo V; Lusivika-Nzinga C; Ramier C; Antwerpes S; Protopopescu C; Lacombe JM; Pol S; Fontaine H; Mourad A; Carrat F; Duracinsky M; Marcellin F;
Qual Life Res; 2023 Dec; 32(12):3427-3438. PubMed ID: 37587323
[TBL] [Abstract][Full Text] [Related]
11. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Provoost A; Dramé M; Cotte L; Cuzin L; Garraffo R; Rey D; Raffi F; Poizot-Martin I; Pugliese P; Bani-Sadr F;
Aliment Pharmacol Ther; 2018 Aug; 48(3):281-289. PubMed ID: 29901821
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Barré T; Rojas Rojas T; Lacombe K; Protopopescu C; Poizot-Martin I; Nishimwe ML; Zucman D; Esterle L; Billaud E; Aumaitre H; Bouchaud O; Rey D; Piroth L; Salmon-Ceron D; Wittkop L; Sogni P; Carrieri MP; Serfaty L; Marcellin F
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1147-1156. PubMed ID: 33538612
[No Abstract] [Full Text] [Related]
13. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP;
Drug Alcohol Rev; 2017 Mar; 36(2):227-238. PubMed ID: 27073179
[TBL] [Abstract][Full Text] [Related]
14. Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.
Carrieri P; Carrat F; Di Beo V; Bourlière M; Barré T; De Ledinghen V; Pageaux GP; Bureau M; Cagnot C; Dorival C; Delarocque-Astagneau E; Marcellin F; Pol S; Fontaine H; Protopopescu C;
JHEP Rep; 2022 Jun; 4(6):100481. PubMed ID: 35514789
[TBL] [Abstract][Full Text] [Related]
15. Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis.
Wijarnpreecha K; Panjawatanan P; Ungprasert P
J Evid Based Med; 2018 Nov; 11(4):272-277. PubMed ID: 30398032
[TBL] [Abstract][Full Text] [Related]
16. Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the ANRS CO22 HEPATHER cohort.
Lam L; Fontaine H; Lapidus N; Bellet J; Lusivika-Nzinga C; Nicol J; Dorival C; Cagnot C; Hejblum G; Pol S; Bourlière M; Carrat F;
J Viral Hepat; 2023 Mar; 30(3):232-241. PubMed ID: 36529681
[TBL] [Abstract][Full Text] [Related]
17. The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.
Kim HN; Crane HM; Rodriguez CV; Van Rompaey S; Mayer KH; Christopoulos K; Napravnik S; Chander G; Hutton H; McCaul ME; Cachay ER; Mugavero MJ; Moore R; Geng E; Eron JJ; Saag MS; Merrill JO; Kitahata MM
AIDS Behav; 2017 Jul; 21(7):1878-1884. PubMed ID: 28035496
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Carrat F; Fontaine H; Dorival C; Simony M; Diallo A; Hezode C; De Ledinghen V; Larrey D; Haour G; Bronowicki JP; Zoulim F; Asselah T; Marcellin P; Thabut D; Leroy V; Tran A; Habersetzer F; Samuel D; Guyader D; Chazouilleres O; Mathurin P; Metivier S; Alric L; Riachi G; Gournay J; Abergel A; Cales P; Ganne N; Loustaud-Ratti V; D'Alteroche L; Causse X; Geist C; Minello A; Rosa I; Gelu-Simeon M; Portal I; Raffi F; Bourliere M; Pol S;
Lancet; 2019 Apr; 393(10179):1453-1464. PubMed ID: 30765123
[TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study.
Leone S; Lorenzini P; Cozzi-Lepri A; Orofino G; Bernacchia D; Castagna A; Menozzi M; Guaraldi G; Madeddu G; Di Biagio A; Puoti M; Gori A; d'Arminio Monforte A;
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1857-1865. PubMed ID: 31230205
[TBL] [Abstract][Full Text] [Related]
20. Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients.
Ryu JK; Lee SB; Hong SJ; Lee S
Korean J Intern Med; 2001 Mar; 16(1):18-23. PubMed ID: 11417300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
